BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37314471)

  • 1. Head and neck MRI-based T stage and [
    Xie HJ; Sun XS; Zhang X; Xiao BB; Lin DF; Lin XP; Lv XF; Liu LZ; Han F; Zou RH; Li JB; Fan W; Chen QY; Mai HQ; Tang LQ
    Eur Radiol; 2023 Nov; 33(11):7952-7966. PubMed ID: 37314471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of pre-treatment [
    Dong Z; Wang GY; Dai DY; Qin GJ; Tang LL; Xu C; Ma J
    BMC Cancer; 2024 Apr; 24(1):466. PubMed ID: 38622555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
    Xiao BB; Chen QY; Sun XS; Li JB; Luo DH; Sun R; Lin DF; Zhang X; Fan W; Lv XF; Han LJ; Wen YF; Yuan L; Guo SS; Liu LT; Liu SL; Tang QN; Liang YJ; Li XY; Lin C; Guo L; Mai HQ; Tang LQ
    Eur Radiol; 2021 Jul; 31(7):5222-5233. PubMed ID: 33416977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and validation of a nomogram with intratumoral heterogeneity derived from
    Gu B; Zhang J; Ma G; Song S; Shi L; Zhang Y; Yang Z
    BMC Cancer; 2020 Jan; 20(1):37. PubMed ID: 31941465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 18F-FDG PET/MRI as an Initial Staging Procedure for Nasopharyngeal Carcinoma.
    Cao C; Fang Y; Yu B; Xu Y; Qiang M; Tao C; Huang S; Chen X
    J Magn Reson Imaging; 2024 Mar; 59(3):922-928. PubMed ID: 37256732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of simultaneous whole-body
    Chan SC; Yeh CH; Yen TC; Ng SH; Chang JT; Lin CY; Yen-Ming T; Fan KH; Huang BS; Hsu CL; Chang KP; Wang HM; Liao CT
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1297-1308. PubMed ID: 29502310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [
    Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
    Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
    Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment [
    Gihbid A; Cherkaoui Salhi G; El Alami I; Belgadir H; Tawfiq N; Bendahou K; El Mzibri M; Cadi R; El Benna N; Guensi A; Khyatti M
    Ann Nucl Med; 2022 Oct; 36(10):876-886. PubMed ID: 35836088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma.
    Liu FY; Lin CY; Chang JT; Ng SH; Chin SC; Wang HM; Liao CT; Chan SC; Yen TC
    J Nucl Med; 2007 Oct; 48(10):1614-9. PubMed ID: 17873135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 11 C-Choline PET/CT for T Staging and Tumor Volume Delineation in Nasopharyngeal Cancer Patients in Comparison to 18 F-FDG PET/CT.
    Li C; Yang Y; Hu F; Xu Y; Wu B; Huang J; Yang K; Lan X
    Clin Nucl Med; 2023 Jul; 48(7):563-573. PubMed ID: 37115936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival effect of pretreatment FDG-PET-CT on nasopharyngeal cancer.
    Yang PC; Chen WM; Chen M; Shia BC; Wu SY; Chiang CW
    J Formos Med Assoc; 2023 Jan; 122(1):36-46. PubMed ID: 35999158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body
    Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
    Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
    Lin XP; Zhao C; Chen MY; Fan W; Zhang X; Zhi SF; Liang PY
    Ai Zheng; 2008 Sep; 27(9):974-8. PubMed ID: 18799039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of the post-radiotherapy
    Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
    Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
    King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
    Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
    Cheuk DK; Sabin ND; Hossain M; Wozniak A; Naik M; Rodriguez-Galindo C; Krasin MJ; Shulkin BL
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1097-106. PubMed ID: 22532252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
    Chan SC; Chang KP; Fang YD; Tsang NM; Ng SH; Hsu CL; Liao CT; Yen TC
    Laryngoscope; 2017 Jan; 127(1):E22-E28. PubMed ID: 27435352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality radiomics analysis based on [
    Xu H; Lv W; Zhang H; Yuan Q; Wang Q; Wu Y; Lu L
    Eur Radiol; 2023 Oct; 33(10):6677-6688. PubMed ID: 37060444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.